{
    "name": "diatrizoate meglumine/diatrizoate sodium",
    "comment": "Rx",
    "other_names": [
        "Gastrografin",
        "Renocal 76",
        "Renografin",
        "MD-Gastroview"
    ],
    "classes": [
        "Iodinated Contrast Media"
    ],
    "source": "https://reference.medscape.com/drug/gastrografin-diatrizoate-meglumine-diatrizoate-sodium-343770",
    "pregnancy": {
        "common": [
            "Pregnancy Category: B (oral); C (parenteral)",
            "Lactation: Distributed in milk, use caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Distributed in milk, use caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Indicated for retrograde pyelography, CT, and angiography",
                "Not for intrathecal use"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to diatrizoate",
                "Intrathecal use",
                "Myelography"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Personal or family history of bronchial asthma, significant allergies, or previous reactions to contrast agents",
                "Iodine sensitivity",
                "Aspiration may occur following oral administration that may result in serious complications",
                "May cause hypovolemia and hypotension due to fluid loss from hypertonic oral/rectal contrast solutions",
                "Serious thromboembolic events including myocardial infarction and stroke reported with intravascular administration",
                "Severe cutaneous adverse reactions (SCAR) may develop from 1 hour to several weeks after intravascular contrast agent administration; these reactions include Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), acute generalized exanthematous pustulosis (AGEP) and drug reaction with eosinophilia and systemic symptoms (DRESS); reaction severity may increase and time to onset may decrease with repeat administration of contrast agent; prophylactic medications may not prevent or mitigate severe cutaneous adverse reactions; avoid administering MD-76R to patients with a history of a severe cutaneous adverse reaction to MD-76R"
            ],
            "specific": [
                {
                    "type": "FDA MedWatch",
                    "description": [
                        "March 30, 2022: ",
                        "FDA",
                        " recommended newborns and children aged â‰¤3 years have follow-up thyroid monitoring within 3 weeks after receiving iodinated contrast media (ICM) for X-rays and other medical imaging procedures ",
                        "Published studies found underactive thyroid and temporary decreases in thyroid hormone levels were uncommon; however, if identified and treated early, future complications may be prevented ",
                        "Appropriately monitor for signs and symptoms of hypothyroidism and decreased thyroid hormone levels following ICM exposure; consider evaluating thyroid function within 3 weeks, especially in term and preterm neonates and children with some underlying conditions ",
                        "If thyroid dysfunction detected, treat and monitor thyroid function as needed to avoid future complications ",
                        "Certain pediatric patients are at increased risk, including newborns or have very low birth weight, prematurity, or presence of cardiac or other conditions (eg, requiring care in neonatal or pediatric ICUs) ",
                        "Patients with cardiac conditions may be at greatest risk since they often require high doses of contrast during invasive cardiac procedures "
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Anaphylaxis",
            "percent": null
        },
        {
            "name": "Hypoxia",
            "percent": null
        },
        {
            "name": "Erythema",
            "percent": null
        },
        {
            "name": "Tachyarrhythmia",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "Arterial thrombosis",
            "percent": null
        },
        {
            "name": "cardiac arrhythmia",
            "percent": null
        },
        {
            "name": "brachial plexopathy",
            "percent": null
        },
        {
            "name": "chest pain",
            "percent": null
        },
        {
            "name": "choking sensation",
            "percent": null
        },
        {
            "name": "ECG changes",
            "percent": null
        },
        {
            "name": "edema",
            "percent": null
        },
        {
            "name": "flushing",
            "percent": null
        },
        {
            "name": "hypertension",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "myocardial infarction",
            "percent": null
        },
        {
            "name": "venous pain",
            "percent": null
        },
        {
            "name": "ventricular fibrillation",
            "percent": null
        },
        {
            "name": "chills",
            "percent": null
        },
        {
            "name": "headache",
            "percent": null
        },
        {
            "name": "pallor",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "hypothyroidism",
            "percent": null
        },
        {
            "name": "pruritus",
            "percent": null
        },
        {
            "name": "skin rash",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "neutropenia",
            "percent": null
        },
        {
            "name": "anaphylactoid reaction",
            "percent": null
        },
        {
            "name": "burning sensation at injection site",
            "percent": null
        },
        {
            "name": "muscle cramps",
            "percent": null
        },
        {
            "name": "sneezing",
            "percent": null
        },
        {
            "name": "wheezing",
            "percent": null
        },
        {
            "name": "conjunctival petechiae",
            "percent": null
        },
        {
            "name": "lacrimation",
            "percent": null
        }
    ]
}